In both comparisons, adults taking GLP-1 drugs were associated with a significantly higher risk of hair loss, more specifically, 37 percent higher compared to SGLT-2 inhibitors and 68 percent higher than DPP-4 inhibitors
While online clinics offering prescriptions exist, its best to avoid them
Mazdutide Developed by Innovent Biologics in partnership with Eli Lilly, mazdutide is another GLP-1/glucagon dual agonist currently in advanced clinical trials, primarily in China
A patient can lose weight and still need work on blood pressure, cholesterol, fatty liver, sleep, alcohol use, or muscle
Many patients experience a decrease in appetite and initial weight loss within the first 1 to 2 weeks
This process consequently reduces the production of pro-inflammatory factors (e.g., IL-1, TNF-) and mitigates inflammation (49, 74, 75)